[EN] SUBSTITUTED PYRIDINE DERIVATIVES USEFUL AS GSK-3 INHIBITORS<br/>[FR] DÉRIVÉS DE PYRIDINE SUBSTITUÉS UTILES EN TANT QU'AGONISTES DE GSK-3
申请人:BRISTOL MYERS SQUIBB CO
公开号:WO2015069593A1
公开(公告)日:2015-05-14
The disclosure generally relates to compounds of formula I, including their salts, as well as compositions and methods of using the compounds. The compounds are ligands, antagonists of the NR2B receptor and may be useful for the treatment of various disorders of the central nervous system.
该披露通常涉及到I式化合物,包括它们的盐,以及使用这些化合物的组合物和方法。这些化合物是NR2B受体的配体,是其拮抗剂,可能对治疗中枢神经系统的各种疾病有用。